
浏览全部资源
扫码关注微信
400042 重庆,陆军军医大学(第三军医大学)大坪医院神经内科
[ 许志强,E-mail:xzq881@163.com XU Zhiqiang E-mail: xzq881@163.com
收稿:2020-11-17,
修回:2020-12-19,
纸质出版:2021-04-15
移动端阅览
许曼玉, 张园, 易旭, 等. pBDNF过表达对转基因阿尔茨海默病鼠学习记忆功能的影响[J]. 第三军医大学学报, 2021,43(7):629-634.
Manyu XU, Yuan ZAHNG, Xu YI, et al. Exogenetic over-expression of pBDNF affects learning and memory in APPswePS1dE9 transgenic mice[J]. Journal of Third Military Medical University, 2021, 43(7): 629-634.
许曼玉, 张园, 易旭, 等. pBDNF过表达对转基因阿尔茨海默病鼠学习记忆功能的影响[J]. 第三军医大学学报, 2021,43(7):629-634. DOI: 10.16016/j.1000-5404.202011150.
Manyu XU, Yuan ZAHNG, Xu YI, et al. Exogenetic over-expression of pBDNF affects learning and memory in APPswePS1dE9 transgenic mice[J]. Journal of Third Military Medical University, 2021, 43(7): 629-634. DOI: 10.16016/j.1000-5404.202011150.
目的
2
探讨海马注射携带脑源性神经营养因子前肽(pBDNF)基因的腺相关病毒基因整合载体(AAV-pBDNF)对阿尔茨海默病鼠(AD鼠)学习记忆功能的影响及可能机制。
方法
2
选用18只6月龄APP/PS1转基因AD小鼠,采用抛硬币法随机分为空载体对照组、AAV-pBDNF组、AAV-pBDNF+p75NTR抗体组,每组6只。空载体对照组右侧海马注射AAV-GFP(2 μL,1×10
12
vg/mL),AAV-pBDNF组右侧海马注射AAV-pBDNF(2 μL,1×10
12
vg/mL),AAV-pBDNF+p75NTR抗体组右侧海马注射AAV-pBDNF(2 μL,1×10
12
vg/mL)和p75NTR抗体(2 μL,10 μg/mL)。海马注射4周后行Morris水迷宫实验检测AD鼠学习记忆能力的变化。免疫荧光检测AAV-pBDNF在AD鼠脑内转染情况。Western blot检测海马突触后致密蛋白-95(postsynaptic density protein 95
PSD-95)的表达。
结果
2
水迷宫实验结果显示:各组小鼠的运动速度无明显差异。第5天时,对照组与AAV-pBDNF+p75NTR抗体组小鼠的逃避潜伏期均较第1天有明显下降(
P
<
0.05),而AAV-pBDNF组AD鼠的逃避潜伏期虽然也较第1天有所缩短,但差异无统计学意义。AAV-pBDNF组AD小鼠穿越平台次数较其余两组少(
P
<
0.05)。免疫荧光检测结果发现:AAV-pBDNF转染之后,在脑内神经元成功表达pBDNF,而胶质细胞不表达pBDNF。Western blot结果显示:AAV-pBDNF组AD鼠的PSD-95表达量低于对照组和AAV-pBDNF+p75NTR抗体组(
P
<
0.05)。
结论
2
pBDNF可能通过p75NTR受体信号通路下调海马PSD-95的表达,降低AD鼠的学习记忆能力。
Objective
2
To explore the effect and possible machanism of recombinant adeno-associated virus (rAAV) vector containing brain-derived neurotrophic factor propeptide (AAV-pBDNF) on learning and memory in APPswePS1dE9 transgenic mice (Alzheimer's disease
AD).
Methods
2
A total of 18 APPswePS1dE9 transgenic mice were randomly and equally divided into co
ntrol group
AAV-pBDNF group and AAV-pBDNF+p75NTR antibody group. Recombinant AAV-pBDNF vector (2 μL
1×10
12
vg/mL) were stereotaxically injected into the right side of the hippocampus in AAV-pBDNF group
AAV-GFP (2 μL
1×10
12
vg/mL) into that of the control group
and same amount of AAV-pBDNF and p75NTR antibody (2 μL
10 μg/mL) into that of the AAV-pBDNF+p75NTR antibody group. There were 6 mice in each group. Morris water maze test was performed in 4 weeks after hippocampal injection to detect the changes of learning and memory abilities in AD rats. Immunofluorescence assay was used to observe the transfection ofAAV-pBDNF in the brain. Western blotting was employed to measure the expression of postsynaptic density protein 95 (PSD-95) in the hippocampus.
Results
2
The results of Morris water maze showed that no significant difference was seen in the movement speed of each group (
P
>
0.05); the escape incubation period on day 5 in the control group and AAV-pBDNF+p75NTR antibody group was significantly shorter than that of day 1 (
P
<
0.05); similar result was seen in the pBDNF group though no statistical difference (
P
>
0.05); and less platforms were crossed in the AD mice of the pBDNF group than those in the other 2 groups on day 6 in space exploration experiment (
P
<
0.05). Immunofluorescence assay showed that after transfection
pBDNF was expressed in the neurons
but not glial cells in the hippocampus. Western blotting results indicated that the expression of PSD-95 was obviously lower in the AAV-pBDNF group than the other 2 groups (
P
<
0.05).
Conclusion
2
pBDNF inhibits the learning and memory abilities of AD mice by down-regulating hippocampal expression of PSD-95.
许曼玉, 许志强. 不同形态脑源性神经营养因子与阿尔茨海默病关系研究进展[J]. 重庆医学, 2019, 48(6): 1025-1028.
XU M Y, XU Z Q. Research progress on the relationship between different forms of brain-derived neurotrophic factors and Alzheimer's disease[J]. Chongqing Med, 2019, 48(6): 1025-1028.
JOE E, RINGMAN J M. Cognitive symptoms of Alzheimer's disease: clinical management and prevention[J]. BMJ Clin Res Ed, 2019, 367: l6217. DOI:10.1136/bmj.l6217.
FOLTRAN R B, DIAZ S L. BDNF isoforms: a round trip ticket between neurogenesis and serotonin?[J]. J Neurochem, 2016, 138(2): 204-221. DOI:10.1111/jnc.13658.
HARWARD S C, HEDRICK N G, HALL C E, et al. Autocrine BDNF-TrkB signalling within a single dendritic spine[J]. Nature, 2016, 538(7623): 99-103. DOI:10.1038/nature19766.
KUIPERS S D, TRENTANI A, TIRON A, et al. BDNF-induced LTP is associated with rapid Arc/Arg3.1-dependent enhancement in adult hippocampal neurogenesis[J]. Sci Rep, 2016, 6: 21222. DOI:10.1038/srep21222.
CHEN J, ZHANG T, JIAO S, et al. proBDNF accelerates brain amyloid-β deposition and learning and memory impairment in APPswePS1dE9 transgenic mice[J]. J Alzheimers Dis, 2017, 59(3): 941-949. DOI:10.3233/jad-161191.
CHEN J, LI C R, YANG H, et al. proBDNF attenuates hippocampal neurogenesis and induces learning and memory deficits in aged mice[J]. Neurotox Res, 2016, 29(1): 47-53. DOI:10.1007/s12640-015-9568-2.
LIM J Y, REIGHARD C P, CROWTHER D C. The pro-domains of neurotrophins, including BDNF, are linked to Alzheimer's disease through a toxic synergy with Aβ[J]. Hum Mol Genet, 2015, 24(14): 3929-3938. DOI:10.1093/hmg/ddv130.
GUO J, JI Y, DING Y, et al. BDNF pro-peptide regulates dendritic spines via caspase-3[J]. Cell Death Dis, 2016, 7: e2264. DOI:10.1038/cddis.2016.166.
许曼玉, 陈甲, 许志强. AAV-proBDNF对阿尔茨海默病鼠海马DCX阳性细胞数及PSD-95表达的影响[J]. 第三军医大学学报, 2019, 41(2): 95-99. DOI:10.16016/j.1000-5404.201808088.
XU M Y, CHEN J, XU Z Q. Effects of AAV-proBDNF on hippocampal DCX positive cells and PSD-95 expression in Alzheimer's disease mice[J]. J Third Mil Med Univ, 2019, 41(2): 95-99. DOI:10.16016/j.1000-5404.201808088.
ANASTASIA A, DEINHARDT K, CHAO M V, et al. Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction[J]. Nat Commun, 2013, 4: 2490. DOI:10.1038/ncomms3490.
HASHIMOTO K. Regulation of brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain by serotonin[J]. Eur Arch Psychiatry Clin Neurosci, 2016, 266(3): 195-197. DOI:10.1007/s00406-016-0682-9.
ZANIN J P, UNSAIN N, ANASTASIA A. Growth factors and hormones pro-peptides: the unexpected adventures of the BDNF prodomain[J]. J Neurochem, 2017, 141(3): 330-340. DOI:10.1111/jnc.13993.
KOJIMA M, MATSUI K, MIZUI T. BDNF pro-peptide: physiological mechanisms and implications for depression[J]. Cell Tissue Res, 2019, 377(1): 73-79. DOI:10.1007/s00441-019-03034-6.
MIZUI T, HATTORI K, ISHIWATA S, et al. Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia[J]. J Psychiatr Res, 2019, 113: 190-198. DOI:10.1016/j.jpsychires.2019.03.024.
GIZA J I, KIM J, MEYER H C, et al. The BDNF Val66Met prodomain disassembles dendritic spines altering fear extinction circuitry and behavior[J]. Neuron, 2018, 99(1): 163-178. e6. DOI:10.1016/j.neuron.2018.05.024.
YANG B, REN Q, ZHANG J C, et al. Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis[J]. Transl Psychiatry, 2017, 7(5): e1128. DOI:10.1038/tp.2017.95.
LISEK M, FERENC B, STUDZIAN M, et al. Glutamate deregulation in ketamine-induced psychosis-A potential role of PSD95, NMDA receptor and PMCA interaction[J]. Front Cell Neurosci, 2017, 11: 181. DOI:10.3389/fncel.2017.00181.
HORGUSLUOGLU-MOLOCH E, NHO K, RISACHER S L, et al. Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease[J]. Neurobiol Aging, 2017, 60: 92-103. DOI:10.1016/j.neurobiolaging.2017.08.010.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621